Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice

Interleukin-6 (IL-6) has emerged as an important mediator of fatty acid metabolism with paradoxical effects in the liver. Administration of IL-6 has been reported to confer protection against steatosis, but plasma and tissue IL-6 concentrations are elevated in chronic liver diseases, including fatty...

Descripción completa

Detalles Bibliográficos
Autores principales: Vida, Margarita, Gavito, Ana Luisa, Pavón, Francisco Javier, Bautista, Dolores, Serrano, Antonia, Suarez, Juan, Arrabal, Sergio, Decara, Juan, Romero-Cuevas, Miguel, Rodríguez de Fonseca, Fernando, Baixeras, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486858/
https://www.ncbi.nlm.nih.gov/pubmed/26035386
http://dx.doi.org/10.1242/dmm.019166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486858/
https://www.ncbi.nlm.nih.gov/pubmed/26035386
http://dx.doi.org/10.1242/dmm.019166

Ejemplares similares